TY  - JOUR
AU  - Montilla, Ana M
AU  - Gómez-García, Francisco
AU  - Gómez-Arias, Pedro J
AU  - Gay-Mimbrera, Jesús
AU  - Hernández-Parada, Jorge
AU  - Isla-Tejera, Beatriz
AU  - Ruano, Juan
PY  - 2019
DO  - 10.1007/s13555-019-00329-y
SN  - 2193-8210
UR  - https://hdl.handle.net/10668/28260
T2  - Dermatology and therapy
AB  - The JAK/STAT signaling pathway is involved in the immune-mediated inflammatory skin diseases atopic dermatitis (AD), vitiligo, and alopecia areata (AA), and represents a potential target when developing treatments. So far, no drugs targeting this...
LA  - en
KW  - Alopecia areata
KW  - Atopic dermatitis
KW  - Baricitinib
KW  - Cerdulatinib
KW  - Immune-mediated inflammatory skin diseases
KW  - JAK/STAT pathway
KW  - Ruxolitinib
KW  - Tofacitinib
KW  - Upadacitinib
KW  - Vitiligo
TI  - Scoping Review on the Use of Drugs Targeting JAK/STAT Pathway in Atopic Dermatitis, Vitiligo, and Alopecia Areata.
TY  - research article
VL  - 9
ER  -